Biologics Monoclonal Antibodies Drug - Global and China Top Players Market Share and Ranking 2023
- Report Code : AMP2757519
- Published On: Oct, 2024
- Category : Healthcare & Pharma
- Pages : 142
-
According to Ample Market Research, the global market for Biologics Monoclonal Antibodies Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Biologics Monoclonal Antibodies Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Biologics Monoclonal Antibodies Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Cancer grew percent to account for percent of the total market sales, and Autoimmune Disease grew percent.
Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.
This report studies and analyses global Biologics Monoclonal Antibodies Drug status and future trends, to help determine the Biologics Monoclonal Antibodies Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Biologics Monoclonal Antibodies Drug, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Biologics Monoclonal Antibodies Drug market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Biologics Monoclonal Antibodies Drug by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Biologics Monoclonal Antibodies Drug by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Biologics Monoclonal Antibodies Drug key consuming regions, consumption value and demand structure
(5) Biologics Monoclonal Antibodies Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Eli Lilly
Novartis
Merck
Biogen
Sobi
Innovent Biologics
Market segment by Type, covers
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other
Market segment by Application, can be divided into
Cancer
Autoimmune Disease
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Biologics Monoclonal Antibodies Drug product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Biologics Monoclonal Antibodies Drug market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Biologics Monoclonal Antibodies Drug market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Biologics Monoclonal Antibodies Drug industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
-
With tables and figures helping analyze worldwide Biologics Monoclonal Antibodies Drug Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Biologics Monoclonal Antibodies Drug Definition
1.2 Global Biologics Monoclonal Antibodies Drug Market Size and Forecast
1.3 China Biologics Monoclonal Antibodies Drug Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Biologics Monoclonal Antibodies Drug Market Size: China VS Global Growth Rate, 2018-2029
1.6 Biologics Monoclonal Antibodies Drug Market Dynamics
1.6.1 Biologics Monoclonal Antibodies Drug Market Drivers
1.6.2 Biologics Monoclonal Antibodies Drug Market Restraints
1.6.3 Biologics Monoclonal Antibodies Drug Industry Trends
1.6.4 Biologics Monoclonal Antibodies Drug Industry Policy
2 Global Leading Players and Market Share2.1 By Revenue of Biologics Monoclonal Antibodies Drug, Global Market Share by Company, 2018-2023
2.2 Global Biologics Monoclonal Antibodies Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Biologics Monoclonal Antibodies Drug Concentration Ratio
2.4 Global Biologics Monoclonal Antibodies Drug Mergers & Acquisitions, Expansion Plans
2.5 Global Biologics Monoclonal Antibodies Drug Major Companies Product Type
2.6 Head Office and Biologics Monoclonal Antibodies Drug Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking3.1 By Revenue of Biologics Monoclonal Antibodies Drug, China Market Share by Company, 2018-2023
3.2 China Biologics Monoclonal Antibodies Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis4.1 Biologics Monoclonal Antibodies Drug Industry Chain
4.2 Biologics Monoclonal Antibodies Drug Upstream Analysis
4.2.1 Biologics Monoclonal Antibodies Drug Core Raw Materials
4.2.2 Main Manufacturers of Biologics Monoclonal Antibodies Drug Core Raw Materials4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Biologics Monoclonal Antibodies Drug Production Mode
4.6 Biologics Monoclonal Antibodies Drug Procurement Model
4.7 Biologics Monoclonal Antibodies Drug Industry Sales Model and Sales Channels
4.7.1 Biologics Monoclonal Antibodies Drug Sales Model
4.7.2 Biologics Monoclonal Antibodies Drug Typical Distributors
5 Sights by Type5.1 Biologics Monoclonal Antibodies Drug Classification
5.1.1 Infliximab
5.1.2 Rituximab
5.1.3 Trastuzumab
5.1.4 Adalimumab
5.1.5 Other5.2 By Type, Global Biologics Monoclonal Antibodies Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Biologics Monoclonal Antibodies Drug Consumption Value, 2018-2029
6 Sights by Application6.1 Biologics Monoclonal Antibodies Drug Segment by Application
6.1.1 Cancer
6.1.2 Autoimmune Disease
6.1.3 Other6.2 By Application, Global Biologics Monoclonal Antibodies Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Biologics Monoclonal Antibodies Drug Consumption Value, 2018-2029
7 Sales Sights by Region7.1 By Region, Global Biologics Monoclonal Antibodies Drug Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Biologics Monoclonal Antibodies Drug Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Biologics Monoclonal Antibodies Drug & Forecasts, 2018-2029
7.3.2 By Country, North America Biologics Monoclonal Antibodies Drug Market Size Market Share7.4 Europe
7.4.1 Europe Biologics Monoclonal Antibodies Drug Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Biologics Monoclonal Antibodies Drug Market Size Market Share7.5 Asia Pacific
7.5.1 Asia Pacific Biologics Monoclonal Antibodies Drug Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Biologics Monoclonal Antibodies Drug Market Size Market Share7.6 South America
7.6.1 South America Biologics Monoclonal Antibodies Drug Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Biologics Monoclonal Antibodies Drug Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level8.1 By Country, Global Biologics Monoclonal Antibodies Drug Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Biologics Monoclonal Antibodies Drug Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
8.3.2 By Type, U.S. Biologics Monoclonal Antibodies Drug Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Biologics Monoclonal Antibodies Drug Consumption Value Market Share, 2022 VS 20298.4 Europe
8.4.1 Europe Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
8.4.2 By Type, Europe Biologics Monoclonal Antibodies Drug Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Biologics Monoclonal Antibodies Drug Consumption Value Market Share, 2022 VS 20298.5 China
8.5.1 China Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
8.5.2 By Type, China Biologics Monoclonal Antibodies Drug Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Biologics Monoclonal Antibodies Drug Consumption Value Market Share, 2022 VS 20298.6 Japan
8.6.1 Japan Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
8.6.2 By Type, Japan Biologics Monoclonal Antibodies Drug Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Biologics Monoclonal Antibodies Drug Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
8.7.2 By Type, South Korea Biologics Monoclonal Antibodies Drug Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Biologics Monoclonal Antibodies Drug Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Biologics Monoclonal Antibodies Drug Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Biologics Monoclonal Antibodies Drug Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
8.9.2 By Type, India Biologics Monoclonal Antibodies Drug Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Biologics Monoclonal Antibodies Drug Consumption Value Market Share, 2022 VS 20298.10 Middle East & Africa
8.10.1 Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value Market Share, 2022 VS 2029
9 Company Profile9.1 Roche
9.1.1 Roche Company Information, Head Office, Market Area and Industry Position
9.1.2 Roche Company Profile and Main Business
9.1.3 Roche Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.1.4 Roche Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.1.5 Roche Recent Developments9.2 Amgen
9.2.1 Amgen Company Information, Head Office, Market Area and Industry Position
9.2.2 Amgen Company Profile and Main Business
9.2.3 Amgen Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.2.4 Amgen Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.2.5 Amgen Recent Developments9.3 AbbVie
9.3.1 AbbVie Company Information, Head Office, Market Area and Industry Position
9.3.2 AbbVie Company Profile and Main Business
9.3.3 AbbVie Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.3.4 AbbVie Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.3.5 AbbVie Recent Developments9.4 Sanofi
9.4.1 Sanofi Company Information, Head Office, Market Area and Industry Position
9.4.2 Sanofi Company Profile and Main Business
9.4.3 Sanofi Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.4.4 Sanofi Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.4.5 Sanofi Recent Developments9.5 Johnson & Johnson
9.5.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
9.5.2 Johnson & Johnson Company Profile and Main Business
9.5.3 Johnson & Johnson Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.5.4 Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.5.5 Johnson & Johnson Recent Developments9.6 Pfizer
9.6.1 Pfizer Company Information, Head Office, Market Area and Industry Position
9.6.2 Pfizer Company Profile and Main Business
9.6.3 Pfizer Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.6.4 Pfizer Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.6.5 Pfizer Recent Developments
9.7 Eli Lilly
9.7.1 Eli Lilly Company Information, Head Office, Market Area and Industry Position
9.7.2 Eli Lilly Company Profile and Main Business
9.7.3 Eli Lilly Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.7.4 Eli Lilly Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.7.5 Eli Lilly Recent Developments
9.8 Novartis
9.8.1 Novartis Company Information, Head Office, Market Area and Industry Position
9.8.2 Novartis Company Profile and Main Business
9.8.3 Novartis Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.8.4 Novartis Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.8.5 Novartis Recent Developments
9.9 Merck
9.9.1 Merck Company Information, Head Office, Market Area and Industry Position
9.9.2 Merck Company Profile and Main Business
9.9.3 Merck Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.9.4 Merck Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.9.5 Merck Recent Developments9.10 Biogen
9.10.1 Biogen Company Information, Head Office, Market Area and Industry Position
9.10.2 Biogen Company Profile and Main Business
9.10.3 Biogen Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.10.4 Biogen Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.10.5 Biogen Recent Developments
9.11 Sobi
9.11.1 Sobi Company Information, Head Office, Market Area and Industry Position
9.11.2 Sobi Company Profile and Main Business
9.11.3 Sobi Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.11.4 Sobi Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.11.5 Sobi Recent Developments
9.12 Innovent Biologics
9.12.1 Innovent Biologics Company Information, Head Office, Market Area and Industry Position
9.12.2 Innovent Biologics Company Profile and Main Business
9.12.3 Innovent Biologics Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.12.4 Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.12.5 Innovent Biologics Recent Developments
10 Conclusion
11 Appendix11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources11.3 Market Estimation Model
11.4 Disclaimer
-
The Biologics Monoclonal Antibodies Drug Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Biologics Monoclonal Antibodies Drug Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Biologics Monoclonal Antibodies Drug Global and China Top Players has a wide range of applications, including
The Biologics Monoclonal Antibodies Drug Global and China Top Players Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.
The influx of capital into the Biologics Monoclonal Antibodies Drug Global and China Top Players Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
In this highly competitive and rapidly evolving Biologics Monoclonal Antibodies Drug Global and China Top Players Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.
